Eyenovia, Inc(NASDAQ:EYEN) 
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print (MAP) platform technology. The company focuses on to develop clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targe...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-12-30
P
O 7.20
H 9.60
L 7.20
C 8.80
V 52,437,538
10EMA 8.80
20EMA 8.80
60EMA 8.80
120EMA 8.80
250EMA 8.80